Technische Universität Dresden

This study tests whether adding a new drug called obrixtamig to standard chemotherapy can help people with advanced large-cell neuroendocrine carcinoma of the lung, a rare and aggressive cancer. About 75 adults who have not yet started or have only had one round of chemo will rec…

This study tests which of two chemotherapy drugs, treosulfan or melphalan, works better and causes fewer side effects when given before a stem cell transplant for people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). About 220 adults who are already schedule…

This study looks at how the immune system and certain genes affect treatment in people with advanced non-small cell lung cancer. Researchers will collect small tumor samples before and during treatment to study immune markers. The goal is to learn more about why some patients res…

This study creates a registry of 500 adults with myelodysplastic syndromes (MDS) or related blood disorders, including early conditions like CHIP and CCUS. Researchers will collect medical data and blood samples over time to learn how these diseases develop and progress. The goal…